IRF1 and neoplasm: Altering TAM mitochondrial dynamics impacts tumor biology: fusion suppresses M1-TAM polarization by inhibiting IRF1-mediated IL-12 production, while fragmentation activates downstream IRF1 through Parkin-dependent CHIP proteolysis 34.